written by reader Jeff Brown Crispr Based Pitch to Cure Blindness

By docdavidw, May 22, 2020

Jeff Brown is pushing Exponential Tech Investor ($2000 for a year) with a tease for a small biotech expected to enter stage 1 for an injection DNA cure for blindness caused by a genetic disorder. He expects an announcement as soon as today (it didn’t happen) that will cause the stock to at least double with much further advances on rapidly moving to stage 2. I did some research and concluded that the company is Editas (EDIT). It looked sufficiently promising for me to buy some stock and options. Thoughts?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.